Organization: GlycoDesign Inc

Inflazyme to acquire GlycoDesign in all-stock deal

Vancouver’s Inflazyme Pharmceuticals Ltd has acquired GlycoDesign Inc of Toronto in an all-stock transaction valued at $12.8 million. The acquisition (subject to shareholder and regulatory approval) is the latest example of an accelerating trend towards consolidation that is sweeping the biotechnology sector as financing remains scarce. Inflazyme will broaden its portfolio of anti-inflammatory therapies with…